Abstract
LATS1/2 loss enhances tumor immunogenicity to promote antitumor immune responses and tumor regression.
- ©2016 American Association for Cancer Research.
February 2017
Volume 7, Issue 2
Volume 7, Issue 2
Deletion of LATS1/2 Hippo Pathway Kinases Enhances Antitumor Immunity
Jump to section
Advertisement